Curecall start-up

Curecall: a smart SMS tool for better chronic patient monitoring 

Unither Pharmaceuticals wants to strengthen its relationship with pharmaceutical companies by offering them an e-health solution. The collaboration with Pathfinder (a corporate venture builder) has led to the creation of the start-up Curecall, which is developing an intelligent SMS tool to improve monitoring of chronic patients. For Unither, this project will enable it to provide more services to its customers (compliance, real-life data, patient pathways, clinical trials, etc.).

Patient, customer and ophthalmologic benefits

  • Available for each ocular pathology: glaucoma, age-related macular degeneration (AMD), cataract, diabetic maculopathy, diabetic retinopathy, dry eye, ocular allergies and ocular tumours
  • Simplifies patient management
  • Saves time for healthcare professionals by automating their follow-up via SMS
  • Over 20,000 patients monitored
  • Real time data


Unlike applications, SMS is less sensitive to categorical differences such as age

  • 95% open rate and no patient set-up required
  • Higher performance and efficiency than any other communication medium

Who is the solution for?

  • Ophthalmological centres that wish to follow their patients remotely
  • Hospitals & clinics for eye surgery preparation
  • E-health industries
  • Pharmaceutical laboratories and CROs conducting clinical trials


Curecall was launched in January 2020 and has raised €2.3 million in 2 investment rounds. Its mission? To equip healthcare professionals with intelligent and efficient technologies to improve the management of chronic patients through secure conversational medical solutions.